The Laboratory for Cell Analysis (LCA) provides Cytometric Core support to the UCSF Comprehensive Cancer Center. The LCA has the following responsibilities: To provide flow and image cytometers and the technical support needed to make use of these instruments. To educate UCSF students, staff, and faculty in cytometry technology and applications. To develop new cytometric methods and applications. Instruments currently available to Cancer Center members include: a Becton-Dickinson (BD) FACSVantage SE sorter with high-speed cell sorting, three laser excitation, ten detectors, single-cell cloning, and large-particle sorting; two BD FACSCalibur flow cytometers with dual lasers capable of four-color analysis, automated sample loading, and sorting options; BD FACScan flow analyzer; Zeiss Multi-photon Confocal Laser Scanning Microscope with spectral emission detection; PowerGene MacProbe and MacKtype systems for capturing FISH images and karyotyping; Xenogen IVIS Imaging System for in vivo biophotonic imaging; high precision QUIPS image cytometers; four digital video fluorescent microscopes; and three fluorescent microscopes with CCDs. A variety of computer software packages and platforms are available to collect and analyze data. This represents over $2,000,000 in state-of-the-art equipment. In addition, the staff of the LCA offers their expertise in the use of this technology as it applies to numerous biological applications. Training courses in flow cytometry and digital microscopy are offered quarterly to CC members. The LCA website is http://cc.ucsf.edu/1ca/index.htm1.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-04
Application #
6694309
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-27
Project End
2007-01-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794

Showing the most recent 10 out of 192 publications